Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study

Fibroblast Growth Factor (FGF) dependent signalling is frequently activated in cancer by a variety of different mechanisms. However, the downstream signal transduction pathways involved are poorly characterised. Here a quantitative differential phosphoproteomics approach, SILAC, is applied to identi...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 10; no. 1; p. 7950
Main Authors Cunningham, Debbie L, Sarhan, Adil R, Creese, Andrew J, Larkins, Katherine P B, Zhao, Hongyan, Ferguson, Harriet R, Brookes, Katie, Marusiak, Anna A, Cooper, Helen J, Heath, John K
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 14.05.2020
Nature Publishing Group UK
Subjects
1-Phosphatidylinositol 3-kinase
AKT protein
Breast cancer
Cell adhesion
Cell adhesion & migration
Cell Line, Tumor
Cell migration
Cell viability
Drug resistance
Extracellular signal-regulated kinase
Fibroblast growth factor receptor 2
Fibroblast growth factor receptors
Gene Ontology
Humans
Kinases
MAP kinase
Phosphoproteins - metabolism
Phosphorylation
Protein Kinase Inhibitors - pharmacology
Proteomes
Proteomics
Raf protein
Receptor, Fibroblast Growth Factor, Type 2 - antagonists & inhibitors
Receptor, Fibroblast Growth Factor, Type 2 - metabolism
Signal transduction
TOR protein
Triple Negative Breast Neoplasms - pathology
Tumor cell lines
Tumors
Online AccessGet full text

Cover

Abstract Fibroblast Growth Factor (FGF) dependent signalling is frequently activated in cancer by a variety of different mechanisms. However, the downstream signal transduction pathways involved are poorly characterised. Here a quantitative differential phosphoproteomics approach, SILAC, is applied to identify FGF-regulated phosphorylation events in two triple- negative breast tumour cell lines, MFM223 and SUM52, that exhibit amplified expression of FGF receptor 2 (FGFR2) and are dependent on continued FGFR2 signalling for cell viability. Comparative Gene Ontology proteome analysis revealed that SUM52 cells were enriched in proteins associated with cell metabolism and MFM223 cells enriched in proteins associated with cell adhesion and migration. FGFR2 inhibition by SU5402 impacts a significant fraction of the observed phosphoproteome of these cells. This study expands the known landscape of FGF signalling and identifies many new targets for functional investigation. FGF signalling pathways are found to be flexible in architecture as both shared, and divergent, responses to inhibition of FGFR2 kinase activity in the canonical RAF/MAPK/ERK/RSK and PI3K/AKT/PDK/mTOR/S6K pathways are identified. Inhibition of phosphorylation-dependent negative-feedback pathways is observed, defining mechanisms of intrinsic resistance to FGFR2 inhibition. These findings have implications for the therapeutic application of FGFR inhibitors as they identify both common and divergent responses in cells harbouring the same genetic lesion and pathways of drug resistance.
AbstractList Abstract Fibroblast Growth Factor (FGF) dependent signalling is frequently activated in cancer by a variety of different mechanisms. However, the downstream signal transduction pathways involved are poorly characterised. Here a quantitative differential phosphoproteomics approach, SILAC, is applied to identify FGF-regulated phosphorylation events in two triple- negative breast tumour cell lines, MFM223 and SUM52, that exhibit amplified expression of FGF receptor 2 (FGFR2) and are dependent on continued FGFR2 signalling for cell viability. Comparative Gene Ontology proteome analysis revealed that SUM52 cells were enriched in proteins associated with cell metabolism and MFM223 cells enriched in proteins associated with cell adhesion and migration. FGFR2 inhibition by SU5402 impacts a significant fraction of the observed phosphoproteome of these cells. This study expands the known landscape of FGF signalling and identifies many new targets for functional investigation. FGF signalling pathways are found to be flexible in architecture as both shared, and divergent, responses to inhibition of FGFR2 kinase activity in the canonical RAF/MAPK/ERK/RSK and PI3K/AKT/PDK/mTOR/S6K pathways are identified. Inhibition of phosphorylation-dependent negative-feedback pathways is observed, defining mechanisms of intrinsic resistance to FGFR2 inhibition. These findings have implications for the therapeutic application of FGFR inhibitors as they identify both common and divergent responses in cells harbouring the same genetic lesion and pathways of drug resistance.
Fibroblast Growth Factor (FGF) dependent signalling is frequently activated in cancer by a variety of different mechanisms. However, the downstream signal transduction pathways involved are poorly characterised. Here a quantitative differential phosphoproteomics approach, SILAC, is applied to identify FGF-regulated phosphorylation events in two triple- negative breast tumour cell lines, MFM223 and SUM52, that exhibit amplified expression of FGF receptor 2 (FGFR2) and are dependent on continued FGFR2 signalling for cell viability. Comparative Gene Ontology proteome analysis revealed that SUM52 cells were enriched in proteins associated with cell metabolism and MFM223 cells enriched in proteins associated with cell adhesion and migration. FGFR2 inhibition by SU5402 impacts a significant fraction of the observed phosphoproteome of these cells. This study expands the known landscape of FGF signalling and identifies many new targets for functional investigation. FGF signalling pathways are found to be flexible in architecture as both shared, and divergent, responses to inhibition of FGFR2 kinase activity in the canonical RAF/MAPK/ERK/RSK and PI3K/AKT/PDK/mTOR/S6K pathways are identified. Inhibition of phosphorylation-dependent negative-feedback pathways is observed, defining mechanisms of intrinsic resistance to FGFR2 inhibition. These findings have implications for the therapeutic application of FGFR inhibitors as they identify both common and divergent responses in cells harbouring the same genetic lesion and pathways of drug resistance.Fibroblast Growth Factor (FGF) dependent signalling is frequently activated in cancer by a variety of different mechanisms. However, the downstream signal transduction pathways involved are poorly characterised. Here a quantitative differential phosphoproteomics approach, SILAC, is applied to identify FGF-regulated phosphorylation events in two triple- negative breast tumour cell lines, MFM223 and SUM52, that exhibit amplified expression of FGF receptor 2 (FGFR2) and are dependent on continued FGFR2 signalling for cell viability. Comparative Gene Ontology proteome analysis revealed that SUM52 cells were enriched in proteins associated with cell metabolism and MFM223 cells enriched in proteins associated with cell adhesion and migration. FGFR2 inhibition by SU5402 impacts a significant fraction of the observed phosphoproteome of these cells. This study expands the known landscape of FGF signalling and identifies many new targets for functional investigation. FGF signalling pathways are found to be flexible in architecture as both shared, and divergent, responses to inhibition of FGFR2 kinase activity in the canonical RAF/MAPK/ERK/RSK and PI3K/AKT/PDK/mTOR/S6K pathways are identified. Inhibition of phosphorylation-dependent negative-feedback pathways is observed, defining mechanisms of intrinsic resistance to FGFR2 inhibition. These findings have implications for the therapeutic application of FGFR inhibitors as they identify both common and divergent responses in cells harbouring the same genetic lesion and pathways of drug resistance.
Fibroblast Growth Factor (FGF) dependent signalling is frequently activated in cancer by a variety of different mechanisms. However, the downstream signal transduction pathways involved are poorly characterised. Here a quantitative differential phosphoproteomics approach, SILAC, is applied to identify FGF-regulated phosphorylation events in two triple- negative breast tumour cell lines, MFM223 and SUM52, that exhibit amplified expression of FGF receptor 2 (FGFR2) and are dependent on continued FGFR2 signalling for cell viability. Comparative Gene Ontology proteome analysis revealed that SUM52 cells were enriched in proteins associated with cell metabolism and MFM223 cells enriched in proteins associated with cell adhesion and migration. FGFR2 inhibition by SU5402 impacts a significant fraction of the observed phosphoproteome of these cells. This study expands the known landscape of FGF signalling and identifies many new targets for functional investigation. FGF signalling pathways are found to be flexible in architecture as both shared, and divergent, responses to inhibition of FGFR2 kinase activity in the canonical RAF/MAPK/ERK/RSK and PI3K/AKT/PDK/mTOR/S6K pathways are identified. Inhibition of phosphorylation-dependent negative-feedback pathways is observed, defining mechanisms of intrinsic resistance to FGFR2 inhibition. These findings have implications for the therapeutic application of FGFR inhibitors as they identify both common and divergent responses in cells harbouring the same genetic lesion and pathways of drug resistance.
ArticleNumber 7950
Author Ferguson, Harriet R
Brookes, Katie
Creese, Andrew J
Marusiak, Anna A
Cooper, Helen J
Heath, John K
Sarhan, Adil R
Zhao, Hongyan
Larkins, Katherine P B
Cunningham, Debbie L
Author_xml – sequence: 1
  givenname: Debbie L
  surname: Cunningham
  fullname: Cunningham, Debbie L
  email: d.cunningham@bham.ac.uk
  organization: School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. d.cunningham@bham.ac.uk
– sequence: 2
  givenname: Adil R
  surname: Sarhan
  fullname: Sarhan, Adil R
  organization: Department of Medical Laboratory Techniques, Nasiriyah Technical Institute, Southern Technical University, Nasiriyah, 6400, Iraq
– sequence: 3
  givenname: Andrew J
  surname: Creese
  fullname: Creese, Andrew J
  organization: Immunocore, 101 Park Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RY, UK
– sequence: 4
  givenname: Katherine P B
  surname: Larkins
  fullname: Larkins, Katherine P B
  organization: School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
– sequence: 5
  givenname: Hongyan
  surname: Zhao
  fullname: Zhao, Hongyan
  organization: School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
– sequence: 6
  givenname: Harriet R
  surname: Ferguson
  fullname: Ferguson, Harriet R
  organization: Division of Molecular and Cellular Function, School of Biological Science, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK
– sequence: 7
  givenname: Katie
  surname: Brookes
  fullname: Brookes, Katie
  organization: School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
– sequence: 8
  givenname: Anna A
  surname: Marusiak
  fullname: Marusiak, Anna A
  organization: Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, 02-097, Warszawa, Poland
– sequence: 9
  givenname: Helen J
  surname: Cooper
  fullname: Cooper, Helen J
  organization: School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
– sequence: 10
  givenname: John K
  surname: Heath
  fullname: Heath, John K
  email: J.K.Heath@bham.ac.uk
  organization: School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. J.K.Heath@bham.ac.uk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32409632$$D View this record in MEDLINE/PubMed
BookMark eNpdkdFuFCEUhompsbX2BbwwJN54MwoHmJ3xwqSpbjVpYmL0mgBzpkudhSkwTfYRfGtZtzZVCOEkfOeHn_85OQoxICEvOXvLmejeZclV3zUMWNNKJWSze0JOgEnVgAA4elQfk7Ocb1gdCnrJ-2fkWIBkfSvghPz66McRE4bizUQT5jmGjJmWSH_6YDJSHzbe-uJjqCVdX66_QWOGwbuCAy3JzxPSgNem-DukNqHJhToTHCbqcJrye2ro7WLqBeXAzJuY65pTLBi33mWayzLsXpCno5kynt3vp-TH-tP3i8_N1dfLLxfnV42T7ao0ogMAi45zycdRWbS9EVyitS0Ct4PsFHdSrFbYOwtu7Jzs-ch4a9AOWE2fkg8H3XmxWxxctZ7MpOfktybtdDRe_3sS_EZfxzu9Aqi6sgq8uRdI8XbBXPTW571VEzAuWde_rVMppir6-j_0Ji4pVHt7SjAGreCVggPlUsw54fjwGM70Pmx9CFvXsPWfsPWuNr16bOOh5W-04jc22KsP
CitedBy_id crossref_primary_10_1038_s41598_023_46586_y
crossref_primary_10_1038_s41467_021_22101_7
crossref_primary_10_3390_ijms22042008
crossref_primary_10_1098_rsob_210373
crossref_primary_10_1007_s10552_022_01574_x
crossref_primary_10_3390_biomedicines10030601
crossref_primary_10_1038_s41401_022_01017_y
Cites_doi 10.1016/j.bbrc.2008.10.127
10.1038/nrd4281
10.1074/jbc.M402055200
10.1074/jbc.M109.029637
10.1016/j.semcdb.2011.08.009
10.1126/science.276.5314.955
10.1074/jbc.M108733200
10.1038/nature25171
10.18632/oncotarget.8132
10.1038/sj.onc.1203712
10.1074/jbc.M004371200
10.1016/j.semcdb.2016.06.011
10.1042/BJ20101603
10.1128/MCB.16.3.977
10.1002/j.1460-2075.1994.tb06599.x
10.1074/mcp.M200025-MCP200
10.1080/15384101.2015.1041691
10.1074/jbc.M006005200
10.1093/gigascience/giw015
10.1093/emboj/cdf551
10.1074/jbc.273.31.19909
10.1002/j.1460-2075.1994.tb06361.x
10.1016/j.ccr.2010.05.023
10.1074/jbc.M110367200
10.1038/nprot.2008.211
10.1155/2014/962962
10.1517/14728220902942330
10.1038/ncb1547
10.1517/14728222.2014.898064
10.1186/s12929-016-0287-7
10.1038/onc.2009.489
10.1074/jbc.M208475200
10.1016/j.cytogfr.2005.01.001
10.1038/nrm2308
10.1038/onc.2009.44
10.1073/pnas.111114298
10.1074/mcp.M115.053652
10.1186/s13058-014-0406-x
10.1093/nar/gky1106
10.1080/15384101.2016.1151581
10.1016/j.semcdb.2011.09.012
10.1158/2159-8290.CD-11-0107
10.1007/BF02096306
10.1016/j.semcancer.2017.04.016
10.1038/onc.2012.606
10.1093/annonc/mdt419
10.1126/scitranslmed.3005747
10.1080/08977190802556986
10.1101/gad.277137.115
10.1038/nbt.1511
10.1038/sj.onc.1209640
10.1074/jbc.M210837200
10.1073/pnas.88.21.9508
10.1126/science.1199498
10.1093/emboj/21.1.64
10.1158/1078-0432.CCR-11-0699
10.1042/BJ20120938
10.1016/bs.ircmb.2015.07.006
10.1038/s41598-017-04015-x
10.1074/jbc.M109.010702
10.1021/pr9010475
10.1002/j.1460-2075.1994.tb06424.x
10.1128/MCB.01665-08
10.1073/pnas.1015328108
10.1158/1078-0432.CCR-13-0190
10.1038/nrc.2017.8
10.18632/oncotarget.1151
10.1038/nrm3979
10.1016/j.tips.2012.07.001
10.1042/BJ20110892
10.1074/jbc.M109.058453
10.1021/pr101065j
10.1016/S0092-8674(00)80252-4
10.1016/j.cell.2017.02.004
10.1002/wdev.176
10.1074/jbc.270.36.21396
10.1074/jbc.M700906200
10.1128/MCB.16.10.5674
10.1016/j.celrep.2016.02.023
10.1016/j.molcel.2008.03.003
10.1158/2159-8290.CD-16-1000
10.1038/sj.onc.1207692
10.1111/j.1349-7006.2008.00840.x
10.1074/jbc.273.3.1496
10.1016/S0960-9822(03)00329-4
10.1038/nprot.2009.36
10.1038/nmeth.3901
10.1002/dvdy.24514
10.1038/onc.2015.426
10.1186/1471-2164-13-619
10.1038/nrc2780
10.1016/S0092-8674(00)80131-2
10.1016/S0092-8674(00)80405-5
10.1101/gad.887201
10.1210/en.2010-1271
10.1021/acs.jproteome.5b00713
10.1016/j.molcel.2007.06.028
10.1158/0008-5472.CAN-11-3034
10.1016/j.molmed.2011.01.012
10.1038/nrd2792
10.1080/21541248.2016.1228792
10.1073/pnas.1018854108
10.1158/1535-7163.MCT-14-0529
10.1038/nrm2067
10.1038/ncponc0558
10.1158/0008-5472.CAN-09-3746
10.1093/bioinformatics/btp026
10.1002/humu.21187
10.1038/onc.2008.247
10.1126/science.286.5445.1741
10.1038/onc.2012.319
10.1038/ncb1465
10.1016/j.cellsig.2009.04.004
10.1007/978-1-4939-6783-4_16
10.1016/j.molcel.2004.11.055
10.1093/emboj/19.12.2924
10.1126/scisignal.2000021
10.1200/JCO.2010.31.6877
10.1158/1078-0432.CCR-14-3212
10.1128/MCB.12.9.3733
10.1016/j.lfs.2015.03.001
10.1038/onc.2013.113
10.1038/onc.2014.161
10.1038/nbt.3080
10.1074/jbc.C300182200
10.1158/2159-8290.CD-15-1246
10.1158/1078-0432.CCR-10-2727
ContentType Journal Article
Copyright The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/s41598-020-64534-y
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Science Database
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic

MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID 10_1038_s41598_020_64534_y
32409632
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAADF
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFGXO
AFKRA
AFPKN
AJTQC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
DIK
DWQXO
EBD
EBS
ECM
EIF
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
NPM
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNT
RNTTT
RPM
SNYQT
UKHRP
AAYXX
ALIPV
C6C
CITATION
EBLON
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c467t-38222bec1141ff5beb9a314ebb6e21bd4851c4377e9cb2cf8c491f016aebde963
IEDL.DBID RPM
ISSN 2045-2322
IngestDate Tue Sep 17 21:29:19 EDT 2024
Sat Aug 17 04:28:36 EDT 2024
Fri Sep 13 05:17:47 EDT 2024
Fri Aug 23 00:45:32 EDT 2024
Thu May 23 23:39:14 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c467t-38222bec1141ff5beb9a314ebb6e21bd4851c4377e9cb2cf8c491f016aebde963
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224374/
PMID 32409632
PQID 2403002631
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7224374
proquest_miscellaneous_2404045505
proquest_journals_2403002631
crossref_primary_10_1038_s41598_020_64534_y
pubmed_primary_32409632
PublicationCentury 2000
PublicationDate 2020-05-14
PublicationDateYYYYMMDD 2020-05-14
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-14
  day: 14
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Scientific reports
PublicationTitleAlternate Sci Rep
PublicationYear 2020
Publisher Nature Publishing Group
Nature Publishing Group UK
Publisher_xml – name: Nature Publishing Group
– name: Nature Publishing Group UK
References N Gotoh (64534_CR6) 2008; 99
IS Babina (64534_CR20) 2017; 17
V Chell (64534_CR23) 2013; 32
DR Alessi (64534_CR69) 1994; 13
S-E Ong (64534_CR33) 2002; 1
H Chen (64534_CR43) 2007; 27
AR Sarhan (64534_CR38) 2016; 15
J Cox (64534_CR126) 2008; 26
M Mohammadi (64534_CR46) 1996; 86
S Zimmermann (64534_CR61) 1999; 286
PP Hsu (64534_CR105) 2011; 332
P Vlastaridis (64534_CR51) 2017; 6
M Mohammadi (64534_CR32) 1997; 276
J Wu (64534_CR74) 1991; 88
M Saha (64534_CR57) 2012; 447
KN Dalby (64534_CR78) 1998; 273
H Kotani (64534_CR15) 2016; 35
G Liang (64534_CR17) 2012; 33
F Andre (64534_CR34) 2011; 29
Y Luo (64534_CR44) 2009; 21
A Carracedo (64534_CR123) 2008; 27
MK Dougherty (64534_CR66) 2005; 17
AC Gingras (64534_CR100) 2001; 15
F André (64534_CR18) 2013; 19
BD Lehmann (64534_CR122) 2014; 16
T Kinoshita (64534_CR76) 2008; 377
R Raju (64534_CR7) 2014; 2014
P Langlais (64534_CR87) 2011; 152
AA Samatar (64534_CR72) 2014; 13
RM Stephens (64534_CR59) 1992; 12
ED Lew (64534_CR45) 2009; 2
I Mothe-Satney (64534_CR101) 2000; 275
D Fey (64534_CR71) 2016; 58
L Goyal (64534_CR24) 2017; 7
JR Brewer (64534_CR4) 2016; 30
A Grigoriadis (64534_CR30) 2012; 13
A Beenken (64534_CR3) 2009; 8
64534_CR5
B Pérez-Benavente (64534_CR48) 2013; 4
64534_CR2
A Lasorella (64534_CR11) 2017; 19
B Magnuson (64534_CR96) 2012; 441
DW Huang (64534_CR130) 2009; 4
SR Datta (64534_CR50) 1997; 91
D Kim (64534_CR94) 2009; 27
DM Gwinn (64534_CR89) 2008; 30
L Polzien (64534_CR109) 2009; 284
A von Kriegsheim (64534_CR64) 2006; 8
CJ Jensen (64534_CR79) 1999; 274
J Wang (64534_CR25) 2015; 34
RA Saxton (64534_CR85) 2017; 168
T Kobayashi (64534_CR65) 2010; 31
IB Weinstein (64534_CR112) 2006; 3
RJ Youle (64534_CR111) 2008; 9
A Pearson (64534_CR22) 2016; 6
NN Danial (64534_CR110) 2008; 27
N Dumaz (64534_CR60) 2003; 278
R Sharpe (64534_CR31) 2011; 17
H Patani (64534_CR21) 2016; 7
R Brough (64534_CR119) 2011; 1
O Meyuhas (64534_CR93) 2015; 320
H-T Tzeng (64534_CR42) 2016; 23
N Turner (64534_CR27) 2010; 29
DM Ornitz (64534_CR1) 2015; 4
M Frodin (64534_CR82) 2000; 19
S Sato (64534_CR67) 2004; 279
A Lachmann (64534_CR52) 2009; 25
S Tyanova (64534_CR129) 2016; 13
CF Zheng (64534_CR68) 1994; 13
J Zhao (64534_CR113) 2011; 22
N Turner (64534_CR40) 2010; 70
S Corbalan-Garcia (64534_CR116) 1996; 16
G Pages (64534_CR70) 1994; 13
J Campbell (64534_CR120) 2016; 14
LM Heiser (64534_CR26) 2012; 109
C Klijn (64534_CR124) 2014; 33
SH Ong (64534_CR55) 2001; 98
F Iorio (64534_CR118) 2016; 166
J Cox (64534_CR127) 2009; 4
AK Freeman (64534_CR114) 2011; 22
V Frattini (64534_CR49) 2018; 553
R Dienstmann (64534_CR14) 2014; 25
T Houles (64534_CR77) 2018; 48
JW Han (64534_CR95) 1995; 270
M Mann (64534_CR37) 2006; 7
K Merienne (64534_CR84) 2000; 19
C Casalou (64534_CR41) 2016; 7
S Shin (64534_CR103) 2014; 33
X Qin (64534_CR99) 2016; 15
R Hackenberg (64534_CR29) 1991; 51
KS Kovacina (64534_CR91) 2003; 278
F Bedussi (64534_CR35) 2014; 18
MR Tavares (64534_CR92) 2015; 131
HA Acosta-Jaquez (64534_CR86) 2009; 29
KG Foster (64534_CR88) 2010; 285
QB She (64534_CR102) 2010; 18
TP Herbert (64534_CR104) 2002; 277
M Kubicek (64534_CR62) 2002; 277
M Frodin (64534_CR81) 2002; 21
SP Ethier (64534_CR28) 1996; 1
M Elkabets (64534_CR121) 2013; 5
H Kouhara (64534_CR54) 1997; 89
H Zhao (64534_CR125) 2015; 14
DL Cunningham (64534_CR36) 2010; 9
A Dang (64534_CR75) 1998; 273
J Cox (64534_CR128) 2011; 10
H Lavoie (64534_CR73) 2015; 16
J Wesche (64534_CR8) 2011; 437
H Greulich (64534_CR10) 2011; 17
A Parish (64534_CR12) 2015; 14
ME Cavet (64534_CR80) 2003; 278
C Chauvin (64534_CR97) 2014; 33
T Sato (64534_CR56) 2009; 13
AM Domina (64534_CR107) 2004; 23
SS Schalm (64534_CR106) 2003; 13
X Gao (64534_CR83) 2009; 284
KE Ross (64534_CR53) 2017; 1558
AN Brooks (64534_CR16) 2012; 18
M Mohammadi (64534_CR47) 1996; 16
Y Perez-Riverol (64534_CR131) 2019; 47
J-I Sakamaki (64534_CR108) 2011; 108
T Helsten (64534_CR13) 2016; 22
T Brummer (64534_CR58) 2006; 25
PP Roux (64534_CR98) 2007; 282
PR Gavine (64534_CR19) 2012; 72
AS Dhillon (64534_CR63) 2002; 21
EV Haar (64534_CR90) 2007; 9
64534_CR115
LS Fink (64534_CR117) 2015; 14
AR Sarhan (64534_CR39) 2017; 7
NS Clayton (64534_CR9) 2017; 246
References_xml – volume: 377
  start-page: 1123
  year: 2008
  ident: 64534_CR76
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2008.10.127
  contributor:
    fullname: T Kinoshita
– volume: 13
  start-page: 928
  year: 2014
  ident: 64534_CR72
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd4281
  contributor:
    fullname: AA Samatar
– volume: 279
  start-page: 33759
  year: 2004
  ident: 64534_CR67
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M402055200
  contributor:
    fullname: S Sato
– volume: 285
  start-page: 80
  year: 2010
  ident: 64534_CR88
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.029637
  contributor:
    fullname: KG Foster
– volume: 22
  start-page: 681
  year: 2011
  ident: 64534_CR114
  publication-title: Semin. Cell Dev. Biol.
  doi: 10.1016/j.semcdb.2011.08.009
  contributor:
    fullname: AK Freeman
– volume: 276
  start-page: 955
  year: 1997
  ident: 64534_CR32
  publication-title: Science
  doi: 10.1126/science.276.5314.955
  contributor:
    fullname: M Mohammadi
– volume: 19
  start-page: 475
  year: 2017
  ident: 64534_CR11
  publication-title: Neuro-Oncology
  contributor:
    fullname: A Lasorella
– volume: 277
  start-page: 7913
  year: 2002
  ident: 64534_CR62
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M108733200
  contributor:
    fullname: M Kubicek
– volume: 553
  start-page: 222
  year: 2018
  ident: 64534_CR49
  publication-title: Nature
  doi: 10.1038/nature25171
  contributor:
    fullname: V Frattini
– volume: 7
  start-page: 24252
  year: 2016
  ident: 64534_CR21
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8132
  contributor:
    fullname: H Patani
– volume: 19
  start-page: 4221
  year: 2000
  ident: 64534_CR84
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203712
  contributor:
    fullname: K Merienne
– ident: 64534_CR115
  doi: 10.1074/jbc.M004371200
– volume: 58
  start-page: 96
  year: 2016
  ident: 64534_CR71
  publication-title: Seminars in Cell and Developmental Biology
  doi: 10.1016/j.semcdb.2016.06.011
  contributor:
    fullname: D Fey
– volume: 437
  start-page: 199
  year: 2011
  ident: 64534_CR8
  publication-title: Biochem. J.
  doi: 10.1042/BJ20101603
  contributor:
    fullname: J Wesche
– volume: 16
  start-page: 977
  year: 1996
  ident: 64534_CR47
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.16.3.977
  contributor:
    fullname: M Mohammadi
– volume: 13
  start-page: 3003
  year: 1994
  ident: 64534_CR70
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1994.tb06599.x
  contributor:
    fullname: G Pages
– volume: 1
  start-page: 376
  year: 2002
  ident: 64534_CR33
  publication-title: Mol. Cell. Proteomics
  doi: 10.1074/mcp.M200025-MCP200
  contributor:
    fullname: S-E Ong
– volume: 14
  start-page: 2121
  year: 2015
  ident: 64534_CR12
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2015.1041691
  contributor:
    fullname: A Parish
– volume: 275
  start-page: 33836
  year: 2000
  ident: 64534_CR101
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M006005200
  contributor:
    fullname: I Mothe-Satney
– volume: 6
  start-page: 1
  year: 2017
  ident: 64534_CR51
  publication-title: GigaScience
  doi: 10.1093/gigascience/giw015
  contributor:
    fullname: P Vlastaridis
– volume: 21
  start-page: 5396
  year: 2002
  ident: 64534_CR81
  publication-title: EMBO J.
  doi: 10.1093/emboj/cdf551
  contributor:
    fullname: M Frodin
– volume: 273
  start-page: 19909
  year: 1998
  ident: 64534_CR75
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.273.31.19909
  contributor:
    fullname: A Dang
– volume: 13
  start-page: 1123
  year: 1994
  ident: 64534_CR68
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1994.tb06361.x
  contributor:
    fullname: CF Zheng
– volume: 18
  start-page: 39
  year: 2010
  ident: 64534_CR102
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.05.023
  contributor:
    fullname: QB She
– volume: 277
  start-page: 11591
  year: 2002
  ident: 64534_CR104
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110367200
  contributor:
    fullname: TP Herbert
– volume: 4
  start-page: 44
  year: 2009
  ident: 64534_CR130
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2008.211
  contributor:
    fullname: DW Huang
– volume: 2014
  start-page: 1
  year: 2014
  ident: 64534_CR7
  publication-title: J. Signal Transduct.
  doi: 10.1155/2014/962962
  contributor:
    fullname: R Raju
– volume: 13
  start-page: 689
  year: 2009
  ident: 64534_CR56
  publication-title: Expert Opin. Ther. Targets
  doi: 10.1517/14728220902942330
  contributor:
    fullname: T Sato
– volume: 9
  start-page: 316
  year: 2007
  ident: 64534_CR90
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1547
  contributor:
    fullname: EV Haar
– volume: 18
  start-page: 665
  year: 2014
  ident: 64534_CR35
  publication-title: Expert Opin. Ther. Targets
  doi: 10.1517/14728222.2014.898064
  contributor:
    fullname: F Bedussi
– volume: 23
  start-page: 70
  year: 2016
  ident: 64534_CR42
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-016-0287-7
  contributor:
    fullname: H-T Tzeng
– volume: 29
  start-page: 2013
  year: 2010
  ident: 64534_CR27
  publication-title: Oncogene
  doi: 10.1038/onc.2009.489
  contributor:
    fullname: N Turner
– volume: 278
  start-page: 18376
  year: 2003
  ident: 64534_CR80
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M208475200
  contributor:
    fullname: ME Cavet
– ident: 64534_CR5
  doi: 10.1016/j.cytogfr.2005.01.001
– volume: 9
  start-page: 47
  year: 2008
  ident: 64534_CR111
  publication-title: Nature Reviews Molecular Cell Biology
  doi: 10.1038/nrm2308
  contributor:
    fullname: RJ Youle
– volume: 27
  start-page: 53
  year: 2008
  ident: 64534_CR110
  publication-title: Oncogene
  doi: 10.1038/onc.2009.44
  contributor:
    fullname: NN Danial
– volume: 98
  start-page: 6074
  year: 2001
  ident: 64534_CR55
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.111114298
  contributor:
    fullname: SH Ong
– volume: 15
  start-page: 1823
  year: 2016
  ident: 64534_CR38
  publication-title: Mol. Cell. Proteomics MCP
  doi: 10.1074/mcp.M115.053652
  contributor:
    fullname: AR Sarhan
– volume: 16
  start-page: 1
  year: 2014
  ident: 64534_CR122
  publication-title: Breast Cancer Res.
  doi: 10.1186/s13058-014-0406-x
  contributor:
    fullname: BD Lehmann
– volume: 47
  start-page: D442
  year: 2019
  ident: 64534_CR131
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gky1106
  contributor:
    fullname: Y Perez-Riverol
– volume: 15
  start-page: 781
  year: 2016
  ident: 64534_CR99
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2016.1151581
  contributor:
    fullname: X Qin
– volume: 22
  start-page: 705
  year: 2011
  ident: 64534_CR113
  publication-title: Seminars in Cell and Developmental Biology
  doi: 10.1016/j.semcdb.2011.09.012
  contributor:
    fullname: J Zhao
– volume: 1
  start-page: 260
  year: 2011
  ident: 64534_CR119
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-11-0107
  contributor:
    fullname: R Brough
– volume: 1
  start-page: 111
  year: 1996
  ident: 64534_CR28
  publication-title: Journal of mammary gland biology and neoplasia
  doi: 10.1007/BF02096306
  contributor:
    fullname: SP Ethier
– volume: 48
  start-page: 53
  year: 2018
  ident: 64534_CR77
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2017.04.016
  contributor:
    fullname: T Houles
– volume: 33
  start-page: 474
  year: 2014
  ident: 64534_CR97
  publication-title: Oncogene
  doi: 10.1038/onc.2012.606
  contributor:
    fullname: C Chauvin
– volume: 25
  start-page: 552
  year: 2014
  ident: 64534_CR14
  publication-title: Annals of Oncology
  doi: 10.1093/annonc/mdt419
  contributor:
    fullname: R Dienstmann
– volume: 5
  start-page: 196ra99
  year: 2013
  ident: 64534_CR121
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3005747
  contributor:
    fullname: M Elkabets
– volume: 27
  start-page: 12
  year: 2009
  ident: 64534_CR94
  publication-title: Growth Factors
  doi: 10.1080/08977190802556986
  contributor:
    fullname: D Kim
– volume: 30
  start-page: 751
  year: 2016
  ident: 64534_CR4
  publication-title: Genes Dev.
  doi: 10.1101/gad.277137.115
  contributor:
    fullname: JR Brewer
– volume: 26
  start-page: 1367
  year: 2008
  ident: 64534_CR126
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1511
  contributor:
    fullname: J Cox
– volume: 25
  start-page: 6262
  year: 2006
  ident: 64534_CR58
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209640
  contributor:
    fullname: T Brummer
– volume: 278
  start-page: 10189
  year: 2003
  ident: 64534_CR91
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M210837200
  contributor:
    fullname: KS Kovacina
– volume: 88
  start-page: 9508
  year: 1991
  ident: 64534_CR74
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.88.21.9508
  contributor:
    fullname: J Wu
– volume: 332
  start-page: 1317
  year: 2011
  ident: 64534_CR105
  publication-title: Science
  doi: 10.1126/science.1199498
  contributor:
    fullname: PP Hsu
– volume: 21
  start-page: 64
  year: 2002
  ident: 64534_CR63
  publication-title: EMBO J.
  doi: 10.1093/emboj/21.1.64
  contributor:
    fullname: AS Dhillon
– volume: 18
  start-page: 1855
  year: 2012
  ident: 64534_CR16
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-11-0699
  contributor:
    fullname: AN Brooks
– volume: 447
  start-page: 159
  year: 2012
  ident: 64534_CR57
  publication-title: Biochem. J.
  doi: 10.1042/BJ20120938
  contributor:
    fullname: M Saha
– volume: 320
  start-page: 41
  year: 2015
  ident: 64534_CR93
  publication-title: International Review of Cell and Molecular Biology
  doi: 10.1016/bs.ircmb.2015.07.006
  contributor:
    fullname: O Meyuhas
– volume: 7
  year: 2017
  ident: 64534_CR39
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-04015-x
  contributor:
    fullname: AR Sarhan
– volume: 284
  start-page: 28004
  year: 2009
  ident: 64534_CR109
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.010702
  contributor:
    fullname: L Polzien
– volume: 9
  start-page: 2317
  year: 2010
  ident: 64534_CR36
  publication-title: J. Proteome Res.
  doi: 10.1021/pr9010475
  contributor:
    fullname: DL Cunningham
– volume: 13
  start-page: 1610
  year: 1994
  ident: 64534_CR69
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1994.tb06424.x
  contributor:
    fullname: DR Alessi
– volume: 29
  start-page: 4308
  year: 2009
  ident: 64534_CR86
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.01665-08
  contributor:
    fullname: HA Acosta-Jaquez
– volume: 108
  start-page: 6085
  year: 2011
  ident: 64534_CR108
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.1015328108
  contributor:
    fullname: J-I Sakamaki
– volume: 19
  start-page: 3693
  year: 2013
  ident: 64534_CR18
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-13-0190
  contributor:
    fullname: F André
– volume: 17
  start-page: 318
  year: 2017
  ident: 64534_CR20
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc.2017.8
  contributor:
    fullname: IS Babina
– volume: 4
  start-page: 956
  year: 2013
  ident: 64534_CR48
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.1151
  contributor:
    fullname: B Pérez-Benavente
– volume: 16
  start-page: 281
  year: 2015
  ident: 64534_CR73
  publication-title: Nature Reviews Molecular Cell Biology
  doi: 10.1038/nrm3979
  contributor:
    fullname: H Lavoie
– volume: 33
  start-page: 531
  year: 2012
  ident: 64534_CR17
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2012.07.001
  contributor:
    fullname: G Liang
– volume: 441
  start-page: 1
  year: 2012
  ident: 64534_CR96
  publication-title: Biochem. J.
  doi: 10.1042/BJ20110892
  contributor:
    fullname: B Magnuson
– volume: 284
  start-page: 33070
  year: 2009
  ident: 64534_CR83
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.058453
  contributor:
    fullname: X Gao
– volume: 10
  start-page: 1794
  year: 2011
  ident: 64534_CR128
  publication-title: J. Proteome Res.
  doi: 10.1021/pr101065j
  contributor:
    fullname: J Cox
– volume: 89
  start-page: 693
  year: 1997
  ident: 64534_CR54
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80252-4
  contributor:
    fullname: H Kouhara
– volume: 168
  start-page: 960
  year: 2017
  ident: 64534_CR85
  publication-title: Cell
  doi: 10.1016/j.cell.2017.02.004
  contributor:
    fullname: RA Saxton
– volume: 4
  start-page: 215
  year: 2015
  ident: 64534_CR1
  publication-title: Wiley Interdiscip. Rev. Dev. Biol.
  doi: 10.1002/wdev.176
  contributor:
    fullname: DM Ornitz
– volume: 270
  start-page: 21396
  year: 1995
  ident: 64534_CR95
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.36.21396
  contributor:
    fullname: JW Han
– volume: 166
  start-page: 740
  year: 2016
  ident: 64534_CR118
  publication-title: Cancer. Cell
  contributor:
    fullname: F Iorio
– volume: 282
  start-page: 14056
  year: 2007
  ident: 64534_CR98
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M700906200
  contributor:
    fullname: PP Roux
– volume: 16
  start-page: 5674
  year: 1996
  ident: 64534_CR116
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.16.10.5674
  contributor:
    fullname: S Corbalan-Garcia
– volume: 14
  start-page: 2490
  year: 2016
  ident: 64534_CR120
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2016.02.023
  contributor:
    fullname: J Campbell
– volume: 30
  start-page: 214
  year: 2008
  ident: 64534_CR89
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2008.03.003
  contributor:
    fullname: DM Gwinn
– volume: 7
  start-page: 252
  year: 2017
  ident: 64534_CR24
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-16-1000
  contributor:
    fullname: L Goyal
– volume: 23
  start-page: 5301
  year: 2004
  ident: 64534_CR107
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207692
  contributor:
    fullname: AM Domina
– volume: 99
  start-page: 1319
  year: 2008
  ident: 64534_CR6
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2008.00840.x
  contributor:
    fullname: N Gotoh
– volume: 273
  start-page: 1496
  year: 1998
  ident: 64534_CR78
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.273.3.1496
  contributor:
    fullname: KN Dalby
– volume: 13
  start-page: 797
  year: 2003
  ident: 64534_CR106
  publication-title: Curr. Biol. CB
  doi: 10.1016/S0960-9822(03)00329-4
  contributor:
    fullname: SS Schalm
– volume: 4
  start-page: 698
  year: 2009
  ident: 64534_CR127
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2009.36
  contributor:
    fullname: J Cox
– volume: 13
  start-page: 731
  year: 2016
  ident: 64534_CR129
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3901
  contributor:
    fullname: S Tyanova
– volume: 274
  start-page: 90
  year: 1999
  ident: 64534_CR79
  publication-title: J Biol Chem
  contributor:
    fullname: CJ Jensen
– volume: 246
  start-page: 493
  year: 2017
  ident: 64534_CR9
  publication-title: Dev. Dyn.
  doi: 10.1002/dvdy.24514
  contributor:
    fullname: NS Clayton
– volume: 35
  start-page: 3587
  year: 2016
  ident: 64534_CR15
  publication-title: Oncogene
  doi: 10.1038/onc.2015.426
  contributor:
    fullname: H Kotani
– volume: 13
  year: 2012
  ident: 64534_CR30
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-13-619
  contributor:
    fullname: A Grigoriadis
– ident: 64534_CR2
  doi: 10.1038/nrc2780
– volume: 86
  start-page: 577
  year: 1996
  ident: 64534_CR46
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80131-2
  contributor:
    fullname: M Mohammadi
– volume: 91
  start-page: 231
  year: 1997
  ident: 64534_CR50
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80405-5
  contributor:
    fullname: SR Datta
– volume: 15
  start-page: 2852
  year: 2001
  ident: 64534_CR100
  publication-title: Genes Dev.
  doi: 10.1101/gad.887201
  contributor:
    fullname: AC Gingras
– volume: 152
  start-page: 1264
  year: 2011
  ident: 64534_CR87
  publication-title: Endocrinology
  doi: 10.1210/en.2010-1271
  contributor:
    fullname: P Langlais
– volume: 14
  start-page: 5077
  year: 2015
  ident: 64534_CR125
  publication-title: J. Proteome Res.
  doi: 10.1021/acs.jproteome.5b00713
  contributor:
    fullname: H Zhao
– volume: 51
  start-page: 5722
  year: 1991
  ident: 64534_CR29
  publication-title: Cancer Res.
  contributor:
    fullname: R Hackenberg
– volume: 27
  start-page: 717
  year: 2007
  ident: 64534_CR43
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2007.06.028
  contributor:
    fullname: H Chen
– volume: 72
  start-page: 2045
  year: 2012
  ident: 64534_CR19
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-11-3034
  contributor:
    fullname: PR Gavine
– volume: 17
  start-page: 283
  year: 2011
  ident: 64534_CR10
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2011.01.012
  contributor:
    fullname: H Greulich
– volume: 8
  start-page: 235
  year: 2009
  ident: 64534_CR3
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2792
  contributor:
    fullname: A Beenken
– volume: 7
  start-page: 270
  year: 2016
  ident: 64534_CR41
  publication-title: Small GTPases
  doi: 10.1080/21541248.2016.1228792
  contributor:
    fullname: C Casalou
– volume: 109
  start-page: 2724
  year: 2012
  ident: 64534_CR26
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.1018854108
  contributor:
    fullname: LM Heiser
– volume: 14
  start-page: 298
  year: 2015
  ident: 64534_CR117
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-14-0529
  contributor:
    fullname: LS Fink
– volume: 7
  start-page: 952
  year: 2006
  ident: 64534_CR37
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm2067
  contributor:
    fullname: M Mann
– volume: 3
  start-page: 448
  year: 2006
  ident: 64534_CR112
  publication-title: Nat. Clin. Pract. Oncol.
  doi: 10.1038/ncponc0558
  contributor:
    fullname: IB Weinstein
– volume: 70
  start-page: 2085
  year: 2010
  ident: 64534_CR40
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-3746
  contributor:
    fullname: N Turner
– volume: 25
  start-page: 684
  year: 2009
  ident: 64534_CR52
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp026
  contributor:
    fullname: A Lachmann
– volume: 31
  start-page: 284
  year: 2010
  ident: 64534_CR65
  publication-title: Hum. Mutat.
  doi: 10.1002/humu.21187
  contributor:
    fullname: T Kobayashi
– volume: 27
  start-page: 5527
  year: 2008
  ident: 64534_CR123
  publication-title: Oncogene
  doi: 10.1038/onc.2008.247
  contributor:
    fullname: A Carracedo
– volume: 286
  start-page: 1741
  year: 1999
  ident: 64534_CR61
  publication-title: Science
  doi: 10.1126/science.286.5445.1741
  contributor:
    fullname: S Zimmermann
– volume: 32
  start-page: 3059
  year: 2013
  ident: 64534_CR23
  publication-title: Oncogene
  doi: 10.1038/onc.2012.319
  contributor:
    fullname: V Chell
– volume: 8
  start-page: 1011
  year: 2006
  ident: 64534_CR64
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1465
  contributor:
    fullname: A von Kriegsheim
– volume: 21
  start-page: 1370
  year: 2009
  ident: 64534_CR44
  publication-title: Cell. Signal.
  doi: 10.1016/j.cellsig.2009.04.004
  contributor:
    fullname: Y Luo
– volume: 1558
  start-page: 333
  year: 2017
  ident: 64534_CR53
  publication-title: Methods Mol. Biol. Clifton NJ
  doi: 10.1007/978-1-4939-6783-4_16
  contributor:
    fullname: KE Ross
– volume: 17
  start-page: 215
  year: 2005
  ident: 64534_CR66
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2004.11.055
  contributor:
    fullname: MK Dougherty
– volume: 19
  start-page: 2924
  year: 2000
  ident: 64534_CR82
  publication-title: EMBO J.
  doi: 10.1093/emboj/19.12.2924
  contributor:
    fullname: M Frodin
– volume: 2
  start-page: ra6
  year: 2009
  ident: 64534_CR45
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.2000021
  contributor:
    fullname: ED Lew
– volume: 29
  start-page: 1236
  year: 2011
  ident: 64534_CR34
  publication-title: J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.
  doi: 10.1200/JCO.2010.31.6877
  contributor:
    fullname: F Andre
– volume: 22
  start-page: 259
  year: 2016
  ident: 64534_CR13
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-14-3212
  contributor:
    fullname: T Helsten
– volume: 12
  start-page: 3733
  year: 1992
  ident: 64534_CR59
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.12.9.3733
  contributor:
    fullname: RM Stephens
– volume: 131
  start-page: 1
  year: 2015
  ident: 64534_CR92
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2015.03.001
  contributor:
    fullname: MR Tavares
– volume: 33
  start-page: 1690
  year: 2014
  ident: 64534_CR103
  publication-title: Oncogene
  doi: 10.1038/onc.2013.113
  contributor:
    fullname: S Shin
– volume: 34
  start-page: 2167
  year: 2015
  ident: 64534_CR25
  publication-title: Oncogene
  doi: 10.1038/onc.2014.161
  contributor:
    fullname: J Wang
– volume: 33
  start-page: 306
  year: 2014
  ident: 64534_CR124
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3080
  contributor:
    fullname: C Klijn
– volume: 278
  start-page: 29819
  year: 2003
  ident: 64534_CR60
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.C300182200
  contributor:
    fullname: N Dumaz
– volume: 6
  start-page: 838
  year: 2016
  ident: 64534_CR22
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-15-1246
  contributor:
    fullname: A Pearson
– volume: 17
  start-page: 5275
  year: 2011
  ident: 64534_CR31
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-2727
  contributor:
    fullname: R Sharpe
SSID ssj0000529419
Score 2.3866432
Snippet Fibroblast Growth Factor (FGF) dependent signalling is frequently activated in cancer by a variety of different mechanisms. However, the downstream signal...
Abstract Fibroblast Growth Factor (FGF) dependent signalling is frequently activated in cancer by a variety of different mechanisms. However, the downstream...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 7950
SubjectTerms 1-Phosphatidylinositol 3-kinase
AKT protein
Breast cancer
Cell adhesion
Cell adhesion & migration
Cell Line, Tumor
Cell migration
Cell viability
Drug resistance
Extracellular signal-regulated kinase
Fibroblast growth factor receptor 2
Fibroblast growth factor receptors
Gene Ontology
Humans
Kinases
MAP kinase
Phosphoproteins - metabolism
Phosphorylation
Protein Kinase Inhibitors - pharmacology
Proteomes
Proteomics
Raf protein
Receptor, Fibroblast Growth Factor, Type 2 - antagonists & inhibitors
Receptor, Fibroblast Growth Factor, Type 2 - metabolism
Signal transduction
TOR protein
Triple Negative Breast Neoplasms - pathology
Tumor cell lines
Tumors
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFD50LYO9jO7utRsa7G2IVJf40peyS7OwhzLKCn0zkiwvoUNOY-chP6H_uufITrZsMIzBYBkLHV2-c_sOwHt3Uikqg8SLokYFRecVN5k23NkqrQuDCLaP8r1Ip1f62_X4eg-mm1wYCqvc7Ilxo64aRzbyEfHGkcKgxMhYsgK4bnS2uOVUP4r8rEMxjQdwIIUmh-3Bp_OL75dbewt5tLQohryZE5WPWjy7KL-M9Cc9Vpqvd8-mfwDn33GTfxxEk0N4PCBI9rEX-RPY8-EpPOxrSq6fwd2XoeQJLt1fbNmHwPqWdQ27mQc8s9g8zOY2RmrhI5t8nVxKTmFFDsEn65ZkeWfB_4yM4MxS0HrHHE2OJSMzf3vKDLtdmRDT06jNYta0eEfKB0pyblkkrX0OV5PzH5-nfKi3wB1ulx1XBBZQpqgiiboeW28Lo4T21qZeCltpRGdOqyzzhbPS1bnThagRMxpvK48r-QXshyb4V8CKDBsK46Sshc7SOpc2x-9SYRVCUl8n8GEz0uWip9Uooztc5WUvlxLlUka5lOsEjjfCKIcl1pa_J0QC77avcXHQUJjgm1VsgxcpYQm87GW3_R0xEWKfZQLZjlS3DYh4e_dNmM8iAXcmicZRv_5_t47gkaTJRVSv-hj2u-XKv0EE09m3w-S8B21-9Pc
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fa9RAEB5qRelLqb9Tq6zgm0TN7l6SFaSU6lkEfRAP-hZ2N5veYdlrkxx4f4L_tTO7yeFpJQQCO0lgZjb7zWbmG4CX9m0tqA1SqlSDAYos61QXUqfW1HmjNCLYmOX7NT-byc_nk_MdGNsdDQrsbgztqJ_UrL18_fN6fYwT_n0sGS_fdLgIUaEYBUJyImS6vgW3uRSSPP7LAPcj1zdXMlND7czNt-7BXeKoQ7_k20vVP_jz7zTKP9al6QHsD4CSnUQPuAc7zt-HO7HF5PoB_PowdEDBmXzJ2pgR6zrWL9mPhccljC38fGFC4hZesumn6TeeUpaRRSzK-pY24pl3F4EgnBnKYe-ZJV9pGe36d--YZtcr7UO1GslczZcdnoEBgmqeOxY4bB_CbPrx--lZOrRfSC1-PftUEHZAE2PElDXNxDijtMikMyZ3PDO1RLBmpSgKp6zhtimtVFmDEFI7UztU4CPY9UvvngBTBQpm2nLeZLLIm5KbEu_LMyMQobomgVejpquryLJRhb_joqyiiSo0URVMVK0TOBqNUY0OUxGvIAWUIkvgxWYY5wqpQnu3XAUZPCgmS-BxtN3mdaPREyi2rLoRIB7u7RG_mAc-7oITq6M8_O8zn8IeJxcj0ld5BLt9u3LPEMv05nlw0N97ifNM
  priority: 102
  providerName: Scholars Portal
Title Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study
URI https://www.ncbi.nlm.nih.gov/pubmed/32409632
https://www.proquest.com/docview/2403002631/abstract/
https://www.proquest.com/docview/2404045505/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC7224374
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SlJZcQvp2mi4q9FacjSWtH73ltQ2FhBAa2JuxZClrmmi3a-9hf0L_dWdke8m2t2JsDJKw0Yysb-RvPgF81seloG2QwiyzGKDItAyLRBahVmVsswIRbMvyvY4v7-T3yWiyBaM-F8aT9rWqjtzD45Grpp5bOX_Uw54nNry5Oks4yejJ4TZsJ0I8CdFbQW-eySjrEmSORTqscZKiRDIKlORIyHC1Cy9IiA6dj2_OR_-AzL-5kk8mn_E-7HWokZ20b_cStox7Bc_bfSRXr-H3ebfNCQ7XB7Zoaa-mZs2M_awczlOsctNKeXYW3rLxt_EtD4lKpBFwsmZBq-3MmXuvAs4UEdUbpskhFoyW9uuvrGC_loXzKWlUZz6d1Xh6mQdKbK6ZF6p9A3fjix9nl2G3x0Ko8RPZhIIAAtoRw6LI2pEyKitEJI1SseGRKiUiMo2dnZhMK65tqmUWWcSJhVGlwQ58Cztu5sx7YFmCFaNCc24jmcQ25SrFdnGkBMJQYwP40vd0Pm-lNHL_C1ykeWuiHE2UexPlqwAOe2Pk3bCqcxIPpKhRRAF8WhfjgKCuKJyZLX0dPCjwCuBda7v143qjB5BsWHVdgcS2N0vQB73odudzB__d8gPscnJBUn6Vh7DTLJbmIwKaRg3QjSfJAJ6dXlzf3A78sgBer2Q68K79B97F_UE
link.rule.ids 230,315,733,786,790,870,891,2236,12083,21416,24346,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829,74102,74659
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgCMELGr8DGxiJN2Rtjt044QWhjVJg7AFtUt8s27HXCuR0TfrQP4H_mjsnLRQkFEWKlIti-Xz2d-fzd4S8dse1wDJIrKoCOCiyrJlR0jBn6yJUBhBsn-V7Xkwu5efpaDoE3NohrXIzJ6aJum4cxsiPkDcOHQbB3y2uGVaNwt3VoYTGTXJLCiExpU9N1TbGgrtYklfDWZljUR61sF7hmTL0meRISLbeXY_-AZl_50r-sfiM98m9ATXS972a75MbPj4gt_s6kuuH5OfpUOYEzPUHXfZpr76lXUO_zyOsU3QeZ3ObsrPgkY4_jr_lDFOJHABO2i0x2k6jv0os4NRionpHHQ6IJcXQfvuWGnq9MjEdSUOZxaxp4U40D3iwuaWJqPYRuRx_uDiZsKHGAnMwRXZMIEAAPYJbxEMYWW8rI7j01hY-57aWgMicFEr5ytnchdLJigfAicbb2oP1PiZ7sYn-KaGVAkFuXJ4HLlURytyW8F3BrQAY6kNG3mx6Wi96Kg2dtsBFqXu9aNCLTnrR64wcbJShB7Nq9e9BkJFX29dgENgVJvpmlWTgQscrI0963W1_h-yD0OY8I2pHq1sBJNvefRPns0S6rXKkbpTP_t-sl-TO5OLrmT77dP7lObmb40BDqld5QPa65cofAoLp7Is0TH8BcPryxA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dq9QwEB30iuKL-G31qhF8k7DbNtu0voh4rdcPLiJe2LeQpIm7KO3ebfdhf4L_2pk0u7oKUgqFprR0JpkzyckZgOd22uRUBolXlccERZQN11Jobk1T-Eojgh1ZvmfF6bn4MJ_NI_-pj7TK3ZgYBuqmszRHPiHdOEoY8nTiIy3i80n9anXBqYIUrbTGchqX4QpGySlVM5BzuZ9voRUtkVZx38w0Lyc9xi7aX0b5k5jlgm8PY9M_gPNv3uQfgai-CTcigmSvR5PfgkuuvQ1Xx5qS2zvw8ySWPMGu-4OtRwqs69nQse_LFmMWW7aLpQlMLbxk9bv6S8aJVmQRfLJhTTPvrHXfgiI4M0RaH5gl51gzmubvXzLNLja6DdvTqM1q0fV4BskH2uTcsyBaexfO67df35zyWG-BWxwuB54TWECbYoqUej8zzlQ6T4UzpnBZahqB6MyKXEpXWZNZX1pRpR4xo3amcdiT78FR27XuAbBKYsNU2yzzqZCFLzNT4nNFanKEpM4n8GL3p9VqlNVQYTk8L9VoF4V2UcEuapvA8c4YKnaxXv12iASe7W9j56BfoVvXbUIbPCgJS-D-aLv960iJEL85S0AeWHXfgIS3D--0y0UQ4JYZyTiKh___rKdwDT1UfXp_9vERXM_Iz0j1VRzD0bDeuMcIZgbzJHjpL3Xf9vA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+responses+to+kinase+inhibition+in+FGFR2-addicted+triple+negative+breast+cancer+cells%3A+a+quantitative+phosphoproteomics+study&rft.jtitle=Scientific+reports&rft.au=Cunningham%2C+Debbie+L&rft.au=Sarhan%2C+Adil+R&rft.au=Creese%2C+Andrew+J&rft.au=Larkins%2C+Katherine+P+B&rft.date=2020-05-14&rft.eissn=2045-2322&rft.volume=10&rft.issue=1&rft.spage=7950&rft_id=info:doi/10.1038%2Fs41598-020-64534-y&rft_id=info%3Apmid%2F32409632&rft.externalDocID=32409632
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon